한국환경보건학회지 (Journal of Environmental Health Sciences)

  • 제49권5호
  • /
  • Pages.237-246
  • /
  • 2023
  • /
  • 1738-4087(pISSN)
  • /
  • 2233-8616(eISSN)
한국환경보건학회 (Korean Society of Environmental Health)
권호 표지
DOI QR코드

DOI QR Code

비소 만성 노출의 건강영향에 대한 고찰

Chronic Exposure to Arsenic and the Effects on Human Health

  • 권정연 (동아대학교 의과대학 예방의학교실) ;
  • 홍영습 (동아대학교 의과대학 예방의학교실)
  • Jung-Yeon Kwon (Department of Preventive Medicine, College of Medicine, Dong-A University) ;
  • Young-Seoub Hong (Department of Preventive Medicine, College of Medicine, Dong-A University)
  • 투고 : 2023.10.11
  • 심사 : 2023.10.24
  • 발행 : 2023.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Arsenic is a metalloid of public health significance due to its unique material properties and toxicity and the widespread pollution in the environment. Arsenic exists as inorganic arsenic and organic arsenic with distinct chemical properties. Its toxicity varies depending on the properties. Objectives: Although the carcinogenicity of arsenic has been identified, the various diseases that occur after acute and chronic exposure to arsenic are not yet clearly known. Methods: Research on the effects of chronic exposure to arsenic on human health was searched and the results were summarized. Results: It has been found that cancer occurs due to exposure to high concentrations of arsenic in areas with elevated exposure to arsenic, but research results have recently been presented on health effects caused by chronic exposure to low concentrations of arsenic. Cancers have also been identified to be related to inorganic arsenic, including skin cancer, lung cancer, and bladder cancer. Significant relationships with neurological diseases, cardiovascular diseases, and diabetes mellitus have been suggested as well. Conclusions: Our results suggest that it is necessary to evaluate the health impact on residents around abandoned metal mines and industrial complexes in South Korea.

키워드

참고문헌

  1. Agency for Toxic Substances and Disease Registry. Addendum to the toxicological profile for arsenic. Available: https://www.atsdr.cdc.gov/toxprofiles/arsenic_addendum.pdf [Accessed 20 September 2023]. 
  2. Tchounwou PB, Yedjou CG, Udensi UK, Pacurari M, Stevens JJ, Patlolla AK, et al. State of the science review of the health effects of inorganic arsenic: perspectives for future research. Environ Toxicol. 2019; 34(2): 188-202.  https://doi.org/10.1002/tox.22673
  3. Tchounwou PB, Wilson B, Ishaque A. Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health. 1999; 14(4): 211-229.  https://doi.org/10.1515/REVEH.1999.14.4.211
  4. Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res. 1999; 59(5): 1041-1048. 
  5. Mandal BK, Ogra Y, Suzuki KT. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol. 2001; 14(4): 371-378.  https://doi.org/10.1021/tx000246h
  6. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, volume 84. Some drinking-water disinfectants and contaminants, including arsenic. Lyon: IARC; 2004. 
  7. United States Environmental Protection Agency. An exposure and risk assessment for arsenic. Available: https://nepis.epa.gov/Exe/ZyNET.exe/2000M05S.txt?ZyActionD=ZyDocument&Client=EPA&Index=1981%20Thru%201985&Docs=&Query=&Time=&EndTime=&SearchMethod=1&TocRestrict=n&Toc=&TocEntry=&QField=&QFieldYear=&QFieldMonth=&QFieldDay=&UseQField=&IntQFieldOp=0&ExtQFieldOp=0&XmlQuery=&File=D%3A%5CZYFILES%5CINDEX%20DATA%5C81THRU85%5CTXT%5C00000005%5C2000M05S.txt&User=ANONYMOUS&Password=anonymous&SortMethod=h%7C-&MaximumDocuments=1&FuzzyDegree=0&ImageQuality=r75g8/r75g8/x150y150g16/i425&Display=hpfr&DefSeekPage=x&SearchBack=ZyActionL&Back=ZyActionS&BackDesc=Results%20page&MaximumPages=1&ZyEntry=5&slide [Accessed 19 September 2023]. 
  8. United States Environmental Protection Agency. Drinking water requirements for states and public water systems. Available: https://www.epa.gov/dwreginfo/chemical-contaminant-rules [Accessed 19 September 2023]. 
  9. Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect. 2013; 121(3): 295-302.  https://doi.org/10.1289/ehp.1205875
  10. Chen QY, Costa M. Arsenic: a global environmental challenge. Annu Rev Pharmacol Toxicol. 2021; 61: 47-63.  https://doi.org/10.1146/annurev-pharmtox-030220-013418
  11. Hanlon DP, Ferm VH. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia. 1977; 33(9): 1221-1222.  https://doi.org/10.1007/BF01922340
  12. Kim YJ, Kim JM. Arsenic toxicity in male reproduction and development. Dev Reprod. 2015; 19(4): 167-180.  https://doi.org/10.12717/DR.2015.19.4.167
  13. Hong YS, Song KH, Chung JY. Health effects of chronic arsenic exposure. J Prev Med Public Health. 2014; 47(5): 245-252.  https://doi.org/10.3961/jpmph.14.035
  14. Centeno JA, Gray MA, Mullick FG, Tchounwou PB, Tseng C. Arsenic in drinking water and health issues. In: Moore TA, Black A, Centeno JA, Harding JS, Trumm DA. editors. Metal contaminants in New Zealand: sources, treatments, and effects on ecology and human health. Christchurch: Resolutionz Press; 2005. p.195-219. 
  15. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, et al. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect. 1999; 107(7): 593-597.  https://doi.org/10.1289/ehp.99107593
  16. Goyer RA, Clarkson TW. Toxic effects of metals. In: Casarett LJ, Doull J, Klaassen CD. editors. Casarett and Doull's toxicology: the basic science of poisons. New York: McGraw-Hill Medical Pub. Division; 2001. p.811-867. 
  17. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicol Lett. 2002; 133(1): 1-16.  https://doi.org/10.1016/S0378-4274(02)00084-X
  18. Tchounwou PB, Patlolla AK, Centeno JA. Carcinogenic and systemic health effects associated with arsenic exposure--a critical review. Toxicol Pathol. 2003; 31(6): 575-588.  https://doi.org/10.1080/01926230390242007
  19. Khairul I, Wang QQ, Jiang YH, Wang C, Naranmandura H. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget. 2017; 8(14): 23905-23926.  https://doi.org/10.18632/oncotarget.14733
  20. Marchiset-Ferlay N, Savanovitch C, Sauvant-Rochat MP. What is the best biomarker to assess arsenic exposure via drinking water? Environ Int. 2012; 39(1): 150-171.  https://doi.org/10.1016/j.envint.2011.07.015
  21. Bae HS, Kang IG, Lee SG, Eom SY, Kim YD, Oh SY, et al. Arsenic exposure and seafood intake in Korean adults. Hum Exp Toxicol. 2017; 36(5): 451-460.  https://doi.org/10.1177/0960327116665673
  22. Ruiz de Luzuriaga AM, Ahsan H, Shea CR. Arsenical keratoses in Bangladesh--update and prevention strategies. Dermatol Clin. 2011; 29(1): 45-51.  https://doi.org/10.1016/j.det.2010.09.003
  23. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, et al. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 2009; 239(2): 184-192.  https://doi.org/10.1016/j.taap.2009.01.010
  24. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect. 2009; 117(3): 455-460.  https://doi.org/10.1289/ehp.11251
  25. Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergeld EK. Variability in human metabolism of arsenic. Environ Res. 2003; 92(2): 85-91.  https://doi.org/10.1016/S0013-9351(02)00081-6
  26. Centeno JA, Tchounwou PB, Patlolla AK, Mullick FG, Murakata L, Meza E, et al. Environmental pathology and health effects of arsenic poisoning. In: Naidu R, Smith E, Owens G, Bhattacharya P, Nadebaum P. editors. Managing arsenic in the environment: from soil to human health. Melbourne: CSIRO Publishing; 2006. p.311-327. 
  27. International Agency for Research on Cancer (IARC). Arsenic and arsenic compounds. Available: https://inchem.org/documents/iarc/vol23/arsenic.html [Accessed 20 September 2023]. 
  28. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning--a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006; 41(10): 2399-2428.  https://doi.org/10.1080/10934520600873571
  29. Minatel BC, Sage AP, Anderson C, Hubaux R, Marshall EA, Lam WL, et al. Environmental arsenic exposure: from genetic susceptibility to pathogenesis. Environ Int. 2018; 112: 183-197.  https://doi.org/10.1016/j.envint.2017.12.017
  30. Liang CP, Chien YC, Jang CS, Chen CF, Chen JS. Spatial analysis of human health risk due to arsenic exposure through drinking groundwater in Taiwan's Pingtung Plain. Int J Environ Res Public Health. 2017; 14(1): 81. 
  31. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev. 2008; 17(8): 1982-1987.  https://doi.org/10.1158/1055-9965.EPI-07-2816
  32. Kitchin KT. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol. 2001; 172(3): 249-261.  https://doi.org/10.1006/taap.2001.9157
  33. Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet. 1988; 1(8582): 414-415.  https://doi.org/10.1016/S0140-6736(88)91207-X
  34. Kurokawa M, Ogata K, Idemori M, Tsumori S, Miyaguni H, Inoue S, et al. Investigation of skin manifestations of arsenicism due to intake of arsenic-contaminated groundwater in residents of Samta, Jessore, Bangladesh. Arch Dermatol. 2001; 137(1): 102-103. 
  35. Smith AH, Goycolea M, Haque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998; 147(7): 660-669.  https://doi.org/10.1093/oxfordjournals.aje.a009507
  36. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 1998; 27(4) :561-569.  https://doi.org/10.1093/ije/27.4.561
  37. Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, et al. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect. 2012; 120(5): 721-726.  https://doi.org/10.1289/ehp.1103534
  38. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol. 2004; 198(3): 394-404.  https://doi.org/10.1016/j.taap.2003.10.016
  39. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev. 1997; 6(8): 589-596. 
  40. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology. 2000; 11(6): 673-679. Erratum in: Epidemiology. 2001; 12(2): 283. 
  41. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect. 2006; 114(8): 1293-1296.  https://doi.org/10.1289/ehp.8832
  42. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995; 55(6): 1296-1300. 
  43. Chiu HF, Ho SC, Yang CY. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan. Lung Cancer. 2004; 46(3): 265-270.  https://doi.org/10.1016/j.lungcan.2004.05.012
  44. Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, et al. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA. 2004; 292(24): 2984-2990.  https://doi.org/10.1001/jama.292.24.2984
  45. Garcia-Esquinas E, Pollan M, Umans JG, Francesconi KA, Goessler W, Guallar E, et al. Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomarkers Prev. 2013; 22(11): 1944-1953. Erratum in: Cancer Epidemiol Biomarkers Prev. 2013; 22(8): 1479. 
  46. Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol. 1993; 71(3): 274-278.  https://doi.org/10.1111/j.1464-410X.1993.tb15942.x
  47. Gabriel HE, Crott JW, Ghandour H, Dallal GE, Choi SW, Keyes MK, et al. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr. 2006; 83(4): 835-841. Erratum in: Am J Clin Nutr. 2006; 84(1): 263. 
  48. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, FactorLitvak P, et al. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr. 2007; 86(4): 1202-1209.  https://doi.org/10.1093/ajcn/86.4.1202
  49. Meliker JR, Slotnick MJ, AvRuskin GA, Schottenfeld D, Jacquez GM, Wilson ML, et al. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control. 2010; 21(5): 745-757.  https://doi.org/10.1007/s10552-010-9503-z
  50. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect. 2000; 108(7): 655-661.  https://doi.org/10.1289/ehp.00108655
  51. Baastrup R, Sorensen M, Balstrom T, Frederiksen K, Larsen CL, Tjonneland A, et al. Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect. 2008; 116(2): 231-237.  https://doi.org/10.1289/ehp.10623
  52. Lin HJ, Sung TI, Chen CY, Guo HR. Arsenic levels in drinking water and mortality of liver cancer in Taiwan. J Hazard Mater. 2013; 262: 1132-1138.  https://doi.org/10.1016/j.jhazmat.2012.12.049
  53. Roh T, Lynch CF, Weyer P, Wang K, Kelly KM, Ludewig G. Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa. Environ Res. 2017; 159: 338-343.  https://doi.org/10.1016/j.envres.2017.08.026
  54. Durant JL, Chen J, Hemond HF, Thilly WG. Elevated incidence of childhood leukemia in Woburn, Massachusetts: NIEHS Superfund Basic Research Program searches for causes. Environ Health Perspect. 1995; 103(Suppl 6): 93-98.  https://doi.org/10.1289/ehp.95103s693
  55. Heck JE, Park AS, Qiu J, Cockburn M, Ritz B. Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood. Int J Hyg Environ Health. 2014; 217(6): 662-668.  https://doi.org/10.1016/j.ijheh.2013.12.003
  56. Rahmani A, Khamutian S, Doosti-Irani A, Shokoohizadeh MJ, Razdari RA, Niksiar S. Association between arsenic concentration of groundwater and mortality from leukemia and urological cancers in the northwest of Iran. Int J Env Health Eng. 2023; 12(5): 18. 
  57. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology. 2003; 24(4-5): 747-753.  https://doi.org/10.1016/S0161-813X(03)00029-9
  58. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2004; 112(13): 1329-1333. Erratum in: Environ Health Perspect. 2004; 112(17): A980. 
  59. Nahar MN, Inaoka T, Fujimura M. A consecutive study on arsenic exposure and intelligence quotient (IQ) of children in Bangladesh. Environ Health Prev Med. 2014; 19(3): 194-199.  https://doi.org/10.1007/s12199-013-0374-2
  60. Nahar MN, Inaoka T, Fujimura M, Watanabe C, Shimizu H, Tasmin S, et al. Arsenic contamination in groundwater and its effects on adolescent intelligence and social competence in Bangladesh with special reference to daily drinking/cooking water intake. Environ Health Prev Med. 2014; 19(2): 151-158. Erratum in: Environ Health Prev Med. 2014; 19(2): 159. 
  61. Rodriguez-Barranco M, Gil F, Hernandez AF, Alguacil J, Lorca A, Mendoza R, et al. Postnatal arsenic exposure and attention impairment in school children. Cortex. 2016; 74: 370-382.  https://doi.org/10.1016/j.cortex.2014.12.018
  62. Vibol S, Hashim JH, Sarmani S. Neurobehavioral effects of arsenic exposure among secondary school children in the Kandal Province, Cambodia. Environ Res. 2015; 137: 329-337.  https://doi.org/10.1016/j.envres.2014.12.001
  63. O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. Int J Environ Res Public Health. 2011; 8(3): 861-874.  https://doi.org/10.3390/ijerph8030861
  64. Hashemi M, Rajabi S, Eghbalian M, Suliburska J, Nasab H. Demographic and anthropometric characteristics and their effect on the concentration of heavy metals (arsenic, lead, chromium, zinc) in children and adolescents. Heliyon. 2023; 9(2): e13621. 
  65. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994; 139(5): 484-492.  https://doi.org/10.1093/oxfordjournals.aje.a117031
  66. Tseng CH, Tseng CP, Chiou HY, Hsueh YM, Chong CK, Chen CJ. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol Lett. 2002; 133(1): 69-76.  https://doi.org/10.1016/S0378-4274(02)00085-1
  67. Feseke SK, St-Laurent J, Anassour-Sidi E, Ayotte P, Bouchard M, Levallois P. Arsenic exposure and type 2 diabetes: results from the 2007-2009 Canadian Health Measures Survey. Health Promot Chronic Dis Prev Can. 2015; 35(4): 63-72.  https://doi.org/10.24095/hpcdp.35.4.01
  68. Castriota F, Acevedo J, Ferreccio C, Smith AH, Liaw J, Smith MT, et al. Obesity and increased susceptibility to arsenic-related type 2 diabetes in Northern Chile. Environ Res. 2018; 167: 248-254.  https://doi.org/10.1016/j.envres.2018.07.022
  69. Nesha K, Islam N, Ferdous N, Nazrul FB, Rasker JJ. Chronic arsenic exposure through drinking water and risk of type 2 diabetes mellitus: a study from Bangladesh. J Family Med Prim Care Open Acc 2. 2018; 2(1): 113. 
  70. Farzan SF, Gossai A, Chen Y, Chasan-Taber L, Baker E, Karagas M. Maternal arsenic exposure and gestational diabetes and glucose intolerance in the New Hampshire birth cohort study. Environ Health. 2016; 15(1): 106. 
  71. Nizam S, Kato M, Yatsuya H, Khalequzzaman M, Ohnuma S, Naito H, et al. Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh. Int J Environ Res Public Health. 2013; 10(3): 1006-1019.  https://doi.org/10.3390/ijerph10031006
  72. Rajiv SV, George M, Nandakumar G. Dermatological manifestations of arsenic exposure. J Skin Sex Transm Dis. 2023; 5(1): 14-21.  https://doi.org/10.25259/JSSTD_3_2022
  73. Ahsan H, Perrin M, Rahman A, Parvez F, Stute M, Zheng Y, et al. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J Occup Environ Med. 2000; 42(12): 1195-1201.  https://doi.org/10.1097/00043764-200012000-00016
  74. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol. 2006; 163(12): 1138-1148.  https://doi.org/10.1093/aje/kwj154
  75. Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, et al. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol. 2011; 174(2): 185-194.  https://doi.org/10.1093/aje/kwr062
  76. Fatmi Z, Abbasi IN, Ahmed M, Kazi A, Kayama F. Burden of skin lesions of arsenicosis at higher exposure through groundwater of taluka Gambat district Khairpur, Pakistan: a cross-sectional survey. Environ Geochem Health. 2013; 35(3): 341-346.  https://doi.org/10.1007/s10653-012-9498-3
  77. Lee MY, Bae ON, Chung SM, Kang KT, Lee JY, Chung JH. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol Appl Pharmacol. 2002; 179(2): 83-88.  https://doi.org/10.1006/taap.2001.9356
  78. Wade TJ, Xia Y, Mumford J, Wu K, Le XC, Sams E, et al. Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control study. Environ Health. 2015; 14: 35. 
  79. James KA, Byers T, Hokanson JE, Meliker JR, Zerbe GO, Marshall JA. Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents. Environ Health Perspect. 2015; 123(2): 128-134.  https://doi.org/10.1289/ehp.1307839
  80. Mendez MA, Gonzalez-Horta C, Sanchez-Ramirez B, Ballinas-Casarrubias L, Ceron RH, Morales DV, et al. Chronic exposure to arsenic and markers of cardiometabolic risk: a cross-sectional study in Chihuahua, Mexico. Environ Health Perspect. 2016; 124(1): 104-111.  https://doi.org/10.1289/ehp.1408742
  81. Richter F, Kloster S, Wodschow K, Hansen B, Schullehner J, Kristiansen SM, et al. Maternal exposure to arsenic in drinking water and risk of congenital heart disease in the offspring. Environ Int. 2022; 160: 107051. 
  82. Gump BB, Heffernan K, Brann LS, Hill DT, Labrie-Cleary C, Jandev V, et al. Exposure to arsenic and subclinical cardiovascular disease in 9- to 11-year-old children, Syracuse, New York. JAMA Netw Open. 2023; 6(6): e2321379. 
  83. Chakraborti D, Mukherjee SC, Pati S, Sengupta MK, Rahman MM, Chowdhury UK, et al. Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? Environ Health Perspect. 2003; 111(9): 1194-1201.  https://doi.org/10.1289/ehp.5966
  84. Hopenhayn C, Huang B, Christian J, Peralta C, Ferreccio C, Atallah R, et al. Profile of urinary arsenic metabolites during pregnancy. Environ Health Perspect. 2003; 111(16): 1888-1891.  https://doi.org/10.1289/ehp.6254
  85. Chen H, Zhang H, Wang X, Wu Y, Zhang Y, Chen S, et al. Prenatal arsenic exposure, arsenic metabolism and neurocognitive development of 2-year-old children in low-arsenic areas. Environ Int. 2023; 174: 107918. 
  86. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009; 29: 381-399.  https://doi.org/10.1146/annurev-nutr-080508-141102
  87. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, et al. Arsenic exposure from drinking water and birth weight. Epidemiology. 2003; 14(5): 593-602.  https://doi.org/10.1097/01.ede.0000072104.65240.69
  88. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, et al. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol. 2009; 169(3): 304-312.  https://doi.org/10.1093/aje/kwn332
  89. Chattopadhyay S, Bhaumik S, Purkayastha M, Basu S, Nag Chaudhuri A, Das Gupta S. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol Lett. 2002; 136(1): 65-76.  https://doi.org/10.1016/S0378-4274(02)00282-5
  90. Cheng YY, Huang NC, Chang YT, Sung JM, Shen KH, Tsai CC, et al. Associations between arsenic in drinking water and the progression of chronic kidney disease: a nationwide study in Taiwan. J Hazard Mater. 2017; 321: 432-439.  https://doi.org/10.1016/j.jhazmat.2016.09.032
  91. Vahter M. Mechanisms of arsenic biotransformation. Toxicology. 2002; 181-182: 211-217.  https://doi.org/10.1016/S0300-483X(02)00285-8
  92. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, Yang MH, et al. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am J Kidney Dis. 2009; 54(5): 859-870.  https://doi.org/10.1053/j.ajkd.2009.06.016
  93. Hsu LI, Hsieh FI, Wang YH, Lai TS, Wu MM, Chen CJ, et al. Arsenic exposure from drinking water and the incidence of CKD in low to moderate exposed areas of Taiwan: a 14-year prospective study. Am J Kidney Dis. 2017; 70(6): 787-797.  https://doi.org/10.1053/j.ajkd.2017.06.012
  94. Sinha D, Mukherjee B, Bindhani B, Dutta K, Saha H, Prasad P, et al. Chronic low level arsenic exposure inflicts pulmonary and systemic inflammation. J Cancer Sci Ther. 2014; 6: 62-69.  https://doi.org/10.4172/1948-5956.1000250
  95. Dutta K, Prasad P, Sinha D. Chronic low level arsenic exposure evokes inflammatory responses and DNA damage. Int J Hyg Environ Health. 2015; 218(6): 564-574.  https://doi.org/10.1016/j.ijheh.2015.06.003